Yonghan Hu

1.2k total citations
35 papers, 874 citations indexed

About

Yonghan Hu is a scholar working on Organic Chemistry, Oncology and Molecular Biology. According to data from OpenAlex, Yonghan Hu has authored 35 papers receiving a total of 874 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Organic Chemistry, 16 papers in Oncology and 13 papers in Molecular Biology. Recurrent topics in Yonghan Hu's work include Metal complexes synthesis and properties (8 papers), Organometallic Complex Synthesis and Catalysis (6 papers) and Synthetic Organic Chemistry Methods (5 papers). Yonghan Hu is often cited by papers focused on Metal complexes synthesis and properties (8 papers), Organometallic Complex Synthesis and Catalysis (6 papers) and Synthetic Organic Chemistry Methods (5 papers). Yonghan Hu collaborates with scholars based in United States, China and Canada. Yonghan Hu's co-authors include John A. Porco, Nicos A. Petasis, Steve Tam, Jennifer R. Thomason, Bei‐Sheng Kang, Lih‐Ling Lin, J. Perry Hall, Jean‐Baptiste Telliez, Xue-Tai Chen and Neal Green and has published in prestigious journals such as Journal of Biological Chemistry, Cancer Research and The Journal of Organic Chemistry.

In The Last Decade

Yonghan Hu

34 papers receiving 821 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yonghan Hu United States 19 456 318 217 151 99 35 874
Blaine M. Sutton United Kingdom 14 451 1.0× 174 0.5× 442 2.0× 105 0.7× 127 1.3× 34 963
Jana A. Lewis United States 14 246 0.5× 712 2.2× 420 1.9× 227 1.5× 98 1.0× 19 1.2k
C. E. Masse United States 21 1.2k 2.6× 390 1.2× 90 0.4× 66 0.4× 160 1.6× 38 1.5k
Boris Cvek Czechia 12 220 0.5× 352 1.1× 311 1.4× 90 0.6× 108 1.1× 22 842
H.H. Fiebig Germany 16 273 0.6× 387 1.2× 440 2.0× 92 0.6× 26 0.3× 41 883
Hellinida Thomadaki Greece 17 133 0.3× 527 1.7× 337 1.6× 119 0.8× 70 0.7× 22 899
Mianli Bian China 21 343 0.8× 393 1.2× 327 1.5× 91 0.6× 60 0.6× 31 1.2k
Zaihui Zhang Canada 13 269 0.6× 436 1.4× 110 0.5× 129 0.9× 66 0.7× 31 792
M. V. Ramana Reddy United States 23 733 1.6× 933 2.9× 488 2.2× 109 0.7× 35 0.4× 80 2.1k
Tianbao Lu United States 20 415 0.9× 569 1.8× 332 1.5× 77 0.5× 21 0.2× 36 1.1k

Countries citing papers authored by Yonghan Hu

Since Specialization
Citations

This map shows the geographic impact of Yonghan Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yonghan Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yonghan Hu more than expected).

Fields of papers citing papers by Yonghan Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yonghan Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yonghan Hu. The network helps show where Yonghan Hu may publish in the future.

Co-authorship network of co-authors of Yonghan Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Yonghan Hu. A scholar is included among the top collaborators of Yonghan Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yonghan Hu. Yonghan Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Yu‐Chuan, Xi Chen, Xiao Liu, et al.. (2023). Abstract 1821: Discovery of XNW21015, a novel, potent HPK1 inhibitor with excellent immune modulatory activity. Cancer Research. 83(7_Supplement). 1821–1821. 2 indexed citations
3.
Ni, Yike, Ariamala Gopalsamy, Derek C. Cole, et al.. (2011). Identification and SAR of a new series of thieno[3,2-d]pyrimidines as Tpl2 kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 21(19). 5952–5956. 27 indexed citations
4.
Hu, Yonghan, Lei Xing, Jennifer R. Thomason, et al.. (2011). Continued exploration of biphenylsulfonamide scaffold as a platform for aggrecanase-1 inhibition. Bioorganic & Medicinal Chemistry Letters. 21(22). 6800–6803. 4 indexed citations
5.
Hu, Yonghan, Derek C. Cole, R. Aldrin Denny, et al.. (2011). Discovery of indazoles as inhibitors of Tpl2 kinase. Bioorganic & Medicinal Chemistry Letters. 21(16). 4758–4761. 17 indexed citations
6.
Hopper, Darrin W., Matthew D. Vera, Jason Xiang, et al.. (2009). Synthesis and biological evaluation of ((4-keto)-phenoxy)methyl biphenyl-4-sulfonamides: A class of potent aggrecanase-1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(9). 2487–2491. 20 indexed citations
7.
Wu, Junjun, Neal Green, Rajeev Hotchandani, et al.. (2009). Selective inhibitors of tumor progression loci-2 (Tpl2) kinase with potent inhibition of TNF-α production in human whole blood. Bioorganic & Medicinal Chemistry Letters. 19(13). 3485–3488. 36 indexed citations
8.
Li, Wei, Yonghan Hu, Jianchang Li, et al.. (2009). 3,4-Disubstituted benzofuran P1′ MMP-13 inhibitors: Optimization of selectivity and reduction of protein binding. Bioorganic & Medicinal Chemistry Letters. 19(16). 4546–4550. 10 indexed citations
9.
Kaila, Neelu, Neal Green, Huan‐Qiu Li, et al.. (2007). Identification of a novel class of selective Tpl2 kinase inhibitors: 4-Alkylamino-[1,7]naphthyridine-3-carbonitriles. Bioorganic & Medicinal Chemistry. 15(19). 6425–6442. 23 indexed citations
11.
Hu, Yonghan, Neal Green, Lori K. Gavrin, et al.. (2006). Inhibition of Tpl2 kinase and TNFα production with quinoline-3-carbonitriles for the treatment of rheumatoid arthritis. Bioorganic & Medicinal Chemistry Letters. 16(23). 6067–6072. 54 indexed citations
12.
Gavrin, Lori K., Neal Green, Yonghan Hu, et al.. (2005). Inhibition of Tpl2 kinase and TNF-α production with 1,7-naphthyridine-3-carbonitriles: Synthesis and structure–activity relationships. Bioorganic & Medicinal Chemistry Letters. 15(23). 5288–5292. 41 indexed citations
13.
Xiang, Jason, Yonghan Hu, Thomas S. Rush, et al.. (2005). Synthesis and biological evaluation of biphenylsulfonamide carboxylate aggrecanase-1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(2). 311–316. 28 indexed citations
14.
Li, Jianchang, Thomas S. Rush, Wěi Li, et al.. (2005). Synthesis and SAR of highly selective MMP-13 inhibitors. Bioorganic & Medicinal Chemistry Letters. 15(22). 4961–4966. 55 indexed citations
15.
Hu, Yonghan, Jason Xiang, Martin DiGrandi, et al.. (2005). Potent, selective, and orally bioavailable matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis. Bioorganic & Medicinal Chemistry. 13(24). 6629–6644. 90 indexed citations
18.
Hu, Yonghan, Bei‐Sheng Kang, Xue‐Tai Chen, et al.. (1993). Structural comparison to the molybdenum site of nitrogenase. Synthesis and crystal structure of binuclear oxomolybdenum(V) complex with both o‐mercaptophenolate and alkoxide ligands. Chinese Journal of Chemistry. 11(2). 137–143. 4 indexed citations
19.
Weng, Linhong, Bei‐Sheng Kang, Xue‐Tai Chen, et al.. (1993). Vanadium(IV) dimer complexes containing [V(o‐C6H4OS)3]2− fragment and caged sodium ions. Chinese Journal of Chemistry. 11(1). 30–39. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026